Safety and efficacy study of oral metronomic vinorelbine combined with trastuzumab (mNH) in HER2-positive metastatic breast cancer: a phase II trial

Breast Cancer Research and Treatment ◽

10.1007/s10549-021-06216-5 ◽

2021 ◽

Author(s):

Zijing Wang ◽

Jiaxuan Liu ◽

Fei Ma ◽

Jiayu Wang ◽

Yang Luo ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Efficacy Study ◽

Her2 Positive ◽

Safety And Efficacy ◽

Metronomic Vinorelbine

Download Full-text

Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trial

Cancer Letters ◽

10.1016/j.canlet.2017.01.027 ◽

2017 ◽

Vol 400 ◽

pp. 276-281 ◽

Author(s):

Emilia Montagna ◽

Antonella Palazzo ◽

Patrick Maisonneuve ◽

Giuseppe Cancello ◽

Monica Iorfida ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Efficacy Study ◽

Safety And Efficacy ◽

Metronomic Vinorelbine

Download Full-text

A Phase II Trial of Oxaliplatin and Trastuzumab in the Treatment of HER2-Positive Metastatic Breast Cancer

Cancer Investigation ◽

10.3109/07357901003631031 ◽

2010 ◽

Vol 28 (8) ◽

pp. 865-871 ◽

Author(s):

Denise A. Yardley ◽

Davey Daniel ◽

Michael Stipanov ◽

D. Randolph Drosick ◽

Mark Mainwaring ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Download Full-text

5020 Pharmacokinetics (PK), safety, and efficacy of trastuzumab (T)-DM1, a HER2 antibody-drug conjugate (ADC), in patients with HER2+ metastatic breast cancer (MBC): phase I and phase II trial results

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)70912-7 ◽

2009 ◽

Vol 7 (2) ◽

pp. 266-267 ◽

Author(s):

H. Burris ◽

S. Vukelja ◽

I. Krop ◽

S. Modi ◽

B. Klencke ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase I ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Antibody Drug Conjugate ◽

Safety And Efficacy ◽

Drug Conjugate ◽

Download Full-text

Abstract PD3-08: A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab

10.1158/1538-7445.sabcs17-pd3-08 ◽

2018 ◽

Author(s):

B Xu ◽

F Ma ◽

Q Ouyang ◽

W Li ◽

Z Jiang ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Her2 Positive ◽

Randomized Phase Ii ◽

Previously Treated

Download Full-text

Abstract PD3-03: SOLTI-1303 PATRICIA phase II trial (STAGE 1) -- Palbociclib and trastuzumab in postmenopausal patients with HER2-positive metastatic breast cancer

10.1158/1538-7445.sabcs18-pd3-03 ◽

2019 ◽

Author(s):

E Ciruelos ◽

P Villagrasa ◽

L Paré ◽

M Oliveira ◽

S Pernas ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Her2 Positive ◽

Download Full-text

PERNETTA: A non-comparative randomized open label phase II trial of pertuzumab (P) + trastuzumab (T) with or without chemotherapy both followed by T-DM1 in case of progression, in patients with HER2-positive metastatic breast cancer (MBC): (SAKK 22/10 / UNICANCER UC-0140/1207)

Annals of Oncology ◽

10.1093/annonc/mdy272.280 ◽

2018 ◽

Vol 29 ◽

pp. viii93 ◽

Author(s):

J. Huober ◽

P. Weder ◽

C. Veyret ◽

B. Thürlimann ◽

A. Xyrafas ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Her2 Positive ◽

Open Label Phase

Download Full-text

Interim results of a prospective, open-label, multicentre phase II trial of the efficacy and safety of vinorelbine (N) and trastuzumab (H) in patients with HER2-positive metastatic breast cancer (MBC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.831 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 831-831 ◽

Author(s):

M. De Wit ◽

N. Harbeck ◽

C. Thomssen ◽

K. Becker ◽

A. Psonka ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Efficacy And Safety ◽

Her2 Positive ◽

Multicentre Phase

Download Full-text

Phase II trial of the Hsp90 inhibitor tanespimycin (Tan) + trastuzumab (T) in patients (pts) with HER2-positive metastatic breast cancer (MBC)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.1027 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 1027-1027 ◽

Author(s):

S. Modi ◽

S. Sugarman ◽

A. Stopeck ◽

H. Linden ◽

W. Ma ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Hsp90 Inhibitor ◽

Download Full-text

Results of a phase II trial of trastuzumab (H) and pertuzumab (P) in patients (pts) with HER2-positive metastatic breast cancer (MBC) who had progressed during trastuzumab therapy

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.1026 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 1026-1026 ◽

Author(s):

K. A. Gelmon ◽

P. Fumoleau ◽

S. Verma ◽

A. M. Wardley ◽

P. F. Conte ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Her2 Positive ◽

Trastuzumab Therapy

Download Full-text

Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy)

Investigational New Drugs ◽

10.1007/s10637-008-9166-8 ◽

2008 ◽

Vol 27 (2) ◽

pp. 166-172 ◽

Author(s):

G. Schilling ◽

M. Bruweleit ◽

N. Harbeck ◽

C. Thomssen ◽

K. Becker ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Combination Chemotherapy ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Efficacy And Safety ◽

Her2 Positive ◽

Multicenter Phase

Download Full-text